Co-Diagnostics, Inc.
CODX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$37,639 | -$35,333 | -$14,238 | $36,659 |
| Dep. & Amort. | $1,377 | $1,230 | $1,283 | $335 |
| Deferred Tax | $0 | -$2,418 | -$4,810 | $930 |
| Stock-Based Comp. | $5,435 | $8,337 | $7,543 | $5,509 |
| Change in WC | $2,755 | $5,641 | $6,192 | -$2,896 |
| Other Non-Cash | -$1,083 | $460 | $10,600 | $544 |
| Operating Cash Flow | -$29,155 | -$22,082 | $6,569 | $41,081 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$748 | -$1,365 | -$1,428 | -$669 |
| Net Acquisitions | -$144 | $0 | $0 | $1,688 |
| Inv. Purchases | -$40,803 | -$110,497 | -$67,996 | $0 |
| Inv. Sales/Matur. | $58,765 | $127,252 | $11,255 | $3,080 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $17,071 | $15,389 | -$58,168 | $4,099 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $104 | $0 | $0 | $0 |
| Stock Repurch. | $0 | -$1,364 | -$14,212 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $178 | $450 |
| Financing Cash Flow | $104 | -$1,364 | -$14,034 | $450 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$11,980 | -$8,057 | -$65,633 | $45,631 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $14,917 | $22,974 | $88,607 | $42,977 |
| End Cash | $2,937 | $14,917 | $22,974 | $88,607 |
| Free Cash Flow | -$29,903 | -$23,447 | $5,141 | $40,412 |